Association of serum osteocalcin and β-CTX with bone mineral density and osteoporosis in older adults

Downloads

Download data is not yet available.
PDF (Tiếng Việt) Download: 0 View: 0

Indexing

CÁC SỐ TỪ 2011-2023
Tạp chí Y Dược Học

Abstract

Background: Osteocalcin and β-CTX are bone turnover markers that may provide additional information on bone remodeling activity beyond bone mineral density measurement. This study aimed to evaluate the association of osteocalcin and β-CTX with bone mineral density and osteoporosis in older adults.

Objectives: To evaluate the associations of serum osteocalcin and β-CTX levels with bone mineral density at different skeletal sites and osteoporosis in older adults.

Materials and methods: A cross-sectional descriptive study was conducted on 471 patients aged 60 years and older who visited Can Tho University of Medicine and Pharmacy Hospital. Bone mineral density was measured at the lumbar spine L1-L4, total hip, and femoral neck using dual-energy X-ray absorptiometry. Serum osteocalcin and β-CTX were quantified using electrochemiluminescence immunoassay. The associations were analyzed using restricted cubic spline models and logistic regression.

Results: The prevalence of osteoporosis was 35.7%. The median bone mineral density (BMD) at the lumbar spine, femoral neck, and total hip was 0.9 (0.8 - 1.1), 0.7 (0.6 - 0.8), and 0.8 (0.7 - 0.9) g/cm², respectively. The osteoporosis group had higher osteocalcin levels than the non-osteoporosis group, 18.2 versus 15.1 ng/mL, p < 0.001; β-CTX levels were also higher, 455.5 versus 376.0 pg/mL, p < 0.001. β-CTX was inversely associated with bone mineral density at the lumbar spine L1-L4 and total hip. Osteocalcin was associated with bone mineral density at all three measurement sites and showed a nonlinear pattern at the femoral neck and total hip. After adjustment, osteocalcin in the highest quartile was associated with osteoporosis, with OR = 1.91 (95% CI: 1.19-3.08), and β-CTX with OR = 1.73 (95% CI: 1.08-2.79).

Conclusion: Serum osteocalcin and β-CTX are associated with bone mineral density and osteoporosis in older adults.

https://doi.org/10.34071/jmp.2027.1.1528
Published 2026-11-12
Fulltext
PDF (Tiếng Việt) Download: 0 View: 0
Language
Issue Vol. 17 (2027)
Section Original Articles
DOI 10.34071/jmp.2027.1.1528
Keywords osteocalcin, beta-crosslaps, mật độ khoáng xương, loãng xương, người cao tuổi

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2026 Hue Journal of Medicine and Pharmacy

Nguyễn, H. T. V., Ngo, H. L., Hoàng, T. T. H., Đào, T. N. P., Hồ, V. Út, Dương, T. A. T., & Lê, T. P. (2026). Association of serum osteocalcin and β-CTX with bone mineral density and osteoporosis in older adults. Hue Journal of Medicine and Pharmacy, 17. https://doi.org/10.34071/jmp.2027.1.1528

Hoang DK, Doan MC, Mai LD, Ho-Le TP, Ho-Pham LT. Burden of osteoporosis in Vietnam: An analysis of population risk. PLoS One. 2021;16(6):e0252592.

Ho-Pham LT, Nguyen TV. The Vietnam Osteoporosis Study: Rationale and design. Osteoporos Sarcopenia. 2017;3(2):90-97.

Nguyen Hoang Thanh Van, Hoang Ngoc Dieu Tram, Le Huu Quyet, Truong Huu Hung. Prevalence of osteoporosis in adults aged 50 and over at Hue University of Medicine and Pharmacy Hospital in 2025. Hue Journal of Medicine and Pharmacy. 2026;16(2)

Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391-420.

Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5(11):908-923.

Schini M, Vilaca T, Gossiel F, Salam S, Eastell R. Bone Turnover Markers: Basic Biology to Clinical Applications. Endocr Rev. 2023;44(3):417-473.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11(3):337-49.

Tian L, Yang R, Wei L, Liu J, Yang Y, Shao F, et al. Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men: A cross-sectional study in Gansu province, Northwestern of China. Medicine (Baltimore). 2017;96(43):e8294.

Brown JP, Don-Wauchope A, Douville P, Albert C, Vasikaran SD. Current use of bone turnover markers in the management of osteoporosis. Clin Biochem. 2022;109-110:1-10.

Nguyen LT, Nguyen UDT, Nguyen TDT, Ho-Pham LT, Nguyen TV. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women. Osteoporos Int. 2018;29(12):2739-2744.

Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4(6):368-81.

Gharibzadeh S, Fahimfar N, Goudarzi S, Yarmohammadi H, Razi F, Khashayar P, et al. Contribution of bone turnover markers (BTMs) and vitamin D to bone health in Iranian elderly women. J Diabetes Metab Disord. 2024;23(2):1871-1877.

Liu Z, Chen R, Jiang Y, Yang Y, He L, Luo C, et al. A meta-analysis of serum osteocalcin level in postmenopausal osteoporotic women compared to controls. BMC Musculoskelet Disord. 2019;20(1):532.

Qu XL, Zheng B, Chen TY, Cao ZR, Qu B, Jiang T. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study. Orthop Surg. 2020;12(1):116-123.

Vasikaran SD, Miura M, Pikner R, Bhattoa HP, Cavalier E. Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis. Calcif Tissue Int. 2023;112(2):148-157.